Accel Wealth Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-99
Closed -$2.34K 635
2023
Q1
$2.34K Hold
99
﹤0.01% 1094
2022
Q4
$2.77K Sell
99
-10
-9% -$256 ﹤0.01% 877
2022
Q3
$3K Sell
109
-15
-12% -$453 ﹤0.01% 903
2022
Q2
$4K Buy
124
+1
+0.8% +$35 ﹤0.01% 839
2022
Q1
$4K Sell
123
-63
-34% -$2.15K ﹤0.01% 832
2021
Q4
$6K Sell
186
-10
-5% -$326 ﹤0.01% 790
2021
Q3
$6K Buy
196
+64
+48% +$2.05K ﹤0.01% 723
2021
Q2
$4K Buy
+132
New +$4.34K ﹤0.01% 825

Other funds holding OGN

Accel Wealth Management's OGN Position: Q2 2023 in Review

Accel Wealth Management sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 99 shares — an estimated $2.34K sold.

Accel Wealth Management first reported a position in OGN in Q2 2021 and held it in 8 quarters. The position peaked at $6K in Q4 2021. 726 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

  • Accel Wealth Management reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
  • Accel Wealth Management sold 99 Organon & Co shares in Q2 2023, an estimated $2.34K.
  • Accel Wealth Management first reported a position in Organon & Co in Q2 2021 and held it in 8 quarters.
  • Accel Wealth Management's Organon & Co position peaked at $6K in Q4 2021.
  • 726 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Accel Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.